首页|血清甲胎蛋白、糖类抗原125对肝细胞癌切除术后患者预后评估价值分析

血清甲胎蛋白、糖类抗原125对肝细胞癌切除术后患者预后评估价值分析

扫码查看
目的 探讨血清甲胎蛋白(AFP)、糖类抗原125(CA125)在肝细胞癌切除术后患者中的预后价值.方法 选取2019 年5 月至2022 年5 月在南阳市中心医院就诊的80 例肝细胞癌患者为调查目标,所有患者均行肝细胞癌切除术,并在术后随访1a.根据患者术后 1a带瘤生存和无瘤生存的预后情况分为预后良好组和预后不良组.采用多因素Logistic分析评估肝细胞癌切除术后患者预后不良的独立危险因素.结果 80 例肝细胞癌切除术后患者中,预后良好者66 例(82.50%),预后不良者14 例(17.50%).预后不良组患者术前血清AFP、CA125 水平均高于预后良好组(t=5.228,P<0.001;t=15.580,P<0.001).血清AFP、CA125 高水平是肝细胞癌切除术后患者预后不良的独立危险因素(OR=1.426,P=0.021;OR=1.905,P=0.008).结论 肝细胞癌患者术后预后可能受术前血清AFP及CA125 水平的影响,术前血清AFP、CA125 高水平提示肝细胞癌患者术后具有较高的预后不良风险.
Values of serum alpha-fetoprotein and carbohydrate antigen 125 in prognosis assess-ment of patients with hepatocellular carcinoma after resection
Objective To probe the prognostic value of serum alpha-fetoprotein(AFP)and carbohydrate antigen 125(CA125)in patients with hepatocellular carcinoma after resection.Methods A total of 80 patients with hepatocellular carcinoma admitted to Nanyang Central Hospital Cancer Hospital from May 2019 to May 2022 were regarded as investigation targets.All the patients underwent hepatocellular carcinoma resection and were followed up for 1 year after surgery.Accord-ing to the prognosis of patients with and without tumor 1 year after surgery,they were grouped into the good prognosis and the poor prognosis groups.Multivariate Logistic analysis was utilized to assess the independent risk factors for poor prognosis after hepatocellular carcinoma resection.Results Of the 80 patients with hepatocellular carcinoma,66(82.50%)had good prognosis and 14(17.50%)had poor prognosis.Compared with the good prognosis group,the serum levels of AFP and CA125 before operation in the poor prognosis group was prominently enhanced(t=5.228,P<0.001;t=15.580,P<0.001).High serum levels of AFP and CA125 was independent risk factor for poor prognosis after hepatocellular carcinoma resection(OR=1.426,P=0.021;OR=1.905,P=0.008).Conclusion The postoperative prognosis of patients with hepatocellular carcinoma might be influenced by the preoperative serum AFP and CA125 levels.When the preoperative AFP and CA125 levels are high,the risk of postoperative poor prognosis in patients with hepatocellular carcinoma are enhanced.

hepatocellular carcinomahepatocellular carcinoma resectionalpha-fetoproteincarbohydrate antigen 125prognosis

张仲毅、冯小明、芦翼飞

展开 >

南阳市中心医院肿瘤医院医学检验科,河南 南阳 473000

肝细胞癌 肝细胞癌切除术 甲胎蛋白 糖类抗原125 预后

2024

肿瘤基础与临床
河南省抗癌协会,郑州大学,河南省肿瘤医院,河南省肿瘤研究所

肿瘤基础与临床

影响因子:0.861
ISSN:1673-5412
年,卷(期):2024.37(4)